Loading organizations...
Arve Capital operates as the venture capital arm of a German single family office, deploying strategic capital into early-stage European technology companies. It provides financial backing and operational support to nascent ventures, specifically targeting those innovating within the healthcare sector. The firm's strategy focuses on nurturing high-potential tech businesses from foundational stages.
Founded in 2022 and based in Heidelberg, Germany, Arve Capital emerged as the dedicated venture capital division of a German single family office. This establishment reflects a deliberate strategy to channel long-term capital into promising early-stage technology, leveraging the family office's resources for impactful tech innovations.
Arve Capital's primary beneficiaries are early-stage technology companies, particularly those developing solutions within the European healthcare sector. The firm's long-term vision involves fostering significant growth among these nascent businesses, aiming to support groundbreaking technological solutions and meaningfully contribute to the health tech landscape.
Arve Capital has 3 tracked investments across 3 companies. The latest tracked deal is $6.3M Seed in Mirantus Health in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 20, 2025 | Mirantus Health | $6.3M Seed | — | KAI Eberhardt, Katharina Juenger, Entrepreneur First, Noaber, Redstone, Revent |
| Nov 7, 2023 | deepeye | $2.7M Seed | YZR Capital | Monika Steger |
| Sep 7, 2022 | faCellitate | $3.7M Seed | Angelika Vlachou, Timo Schretzmair | Chemovator, R3 Consulting, ROI Verwaltungsgesellschaft |